Diagnosis, Management, & Follow-up Care Of CAD/AMI BARRY BERTOLET, MD CARDIOLOGY ASSOCIATES OF NORTH MS.

Slides:



Advertisements
Similar presentations
Keith A A Fox Royal Infirmary & University of Edinburgh CURE and PCI-CURE.
Advertisements

Treatment of Acute Coronary Syndrome with ST elevation ESC guidelines 2008 Dr. David Tran A&E dept. FVH 22/12/09.
Ischemic cardiopathy. Ischemic cardiopathy is a term used to describe patients whose heart can no longer pump enough blood to the rest of their body due.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Ischaemic Heart Disease for the GP Chris Tracey GPVTS.
Lifesaving information on Heart Attacks Presented to: Members of Virtua’s Health Systems Presented by: Rachel Zeilman.
Coronary Artery Disease. What is coronary artery disease? A narrowing of the coronary arteries that prevents adequate blood supply to the heart muscle.
 What is Coronary Heart Disease?  Who is at Risk for Coronary Heart Disease?  Signs and Symptoms of Coronary Heart Disease.  How Is Coronary Heart.
Ischemic Heart Diseases IHD
Assessment and management of patient with coronary artery disease
Scenario 1Scenario 1  58 year old man  30 minute history of severe chest pain, 10/10, radiating to jaw, not relieved by anything, associated with sweating.
By Dr. Zahoor 1. ISCHAEMIC HEART DISEASE (IHD) Why myocardial ischaemia occurs?  Myocardial Ischaemia occurs when there is less supply of oxygen to the.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
Women and Heart Disease: Triage Criteria Symptoms versus Reality.
Angina and MI.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 53 Management of ST-Elevation Myocardial Infarction.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
Unstable Angina /Non-ST Elevation Myocardial Infarction Critical Pathway Toolkit Adapted from Dr Chris Cannon STRIVE Scientific Committee – 2008 Based.
Dr Jayachandran Thejus.  Coronary artery disease-  Block in coronary artery due to plaque or thrombus  Leads to myocardial ischemia manifested as chest.
Management of Stable Angina SIGN 96
Management of Chronic Stable Angina AIMGP Seminar Series Mirek Otremba 2007.
Coronary Artery Disease Presented by: Marissa V. Dacumos Batch 17
Unstable angina and arterial hypertension Leszek Kinasz, MD American Heart of Poland Ustron, Poland.
CARDIOVASCULAR CARE of the OUTPATIENT Diane M. Enzweiler, MSN, ANP-BC St. Elizabeth Physicians: Heart and Vascular.
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
Coronary Artery Disease. Causes of Coronary Heart Disease Coronary heart disease is caused by the build up of fatty deposits on your artery walls. Coronary.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
Myocardial Ischemia: Concepts in Management Topics in Clinical Medicine February 14, 2007.
One patient, two years, three choices, four PCI ZHAO Peng Cardiology , the Affiliated Hospital of Medical College of CPAPF, Tianjin, China.
Non-communicable Disease Coronary Heart Disease
Cardiovascular Monitoring Coronary Artery Disease.
 This disease Narrows the blood vessels that carry oxygen-rich blood to your heart. This happens because of plaque build up in the vessels.  The coronary.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
TACTICS- TIMI 18 Treat Angina with Aggrastat TM and Determine Cost of Therapy with an Invasive or Conservative Strategy.
Dr. Sohail Bashir Sulehria
COMMON LIFESTYLE DISEASES: CHD EMS 355 By: Dr. Bushra Bilal.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Laboratory Testing For Cardiovascular Risk
 Coronary artery disease (also called CAD) is the most common type of heart disease. It is also the leading cause of death for both men and women in.
Cardiac update for GPs - Chest pain/angina Sanjay Sastry Consultant Cardiologist Royal Bolton Hospital Royal Bolton Hospital Manchester Heart Centre Wigan.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
Acute Coronary Syndromes Chapter 12 Cardiovascular Disorders Medical Surgical Nursing II.
Coronary Artery Disease Po Hu IMG 310 Sectional Anatomy for Medical Imaging Summer Pathology Presentation Project.
Management Strategies for Post-Intervention in Patients with CAD VBWG.
© Continuing Medical Implementation ® …...bridging the care gap Geriovascular Prevention Optimizing Prevention of Cardiovascular Disease in the Elderly.
Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Outcomes and Cost-Effectiveness of Coronary.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Acute Coronary Syndrome
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Atherosclerotic Cardiovascular Heart Disease in Women
Women and Cardiovascular Disease
Heart Attack By: Taylor.
Coronary Heart Disease
Risk Stratification of Chest Pain: Best Practices
CORONARY ARTERY DISEASE
Management of ST-Elevation Myocardial Infarction
Ischemic Heart Disease
Ischaemic Heart Disease Acute Coronary Syndrome
Nursing Management: Patients With Coronary Vascular Disorders
Preventive Angioplasty in Myocardial Infarction Trial
Acute Coronary Syndrome (1)
What oral antiplatelet therapy would you choose?
Train-the-Trainer Cases
Train-the-Trainer Cases
Train-the-Trainer Cases
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

Diagnosis, Management, & Follow-up Care Of CAD/AMI BARRY BERTOLET, MD CARDIOLOGY ASSOCIATES OF NORTH MS

What is coronary artery disease? A narrowing of the coronary arteries that prevents adequate blood supply to the heart muscle. Usually caused by atherosclerosis, it may progress to the point where the heart muscle is damaged due to lack of blood supply.

Presentations of CAD ▪ Method of diagnosis of the CAD depends on the presentation

Stable CAD Asymptomatic / Atypical ▪ CT calcium score ▪ Very sensitive ▪ Predictive of future events The BioImage Study. J Am Coll Cardiol. 2015; 65(11):

Stable CAD ▪ Symptoms - Angina ▪ Chest discomfort or tightness ▪ Jaw or arm discomfort ▪ Nausea ▪ Dyspnea ▪ Fatigue ▪ Back pain ▪ Severity of symptoms do not correlate with extent of CAD ▪ Usually symptoms denote at least one blockage > 50% ▪ Diagnostic tests ▪ Need a Functional Test FIRST ▪ Exercise Treadmill Stress Test ▪ With Imaging ▪ Echo ▪ Radionuclide ▪ Pharmacologic Stress Test with Imaging

Think about Radiation Exposure

Stable CAD – What do you do with a negative stress test?

▪ If in doubt, confirm dx of CAD with CT calcium score ▪ Begin cardiac risk factor modification ▪ Lower SBP to < 140 mm Hg ▪ Reduce LDL by 50% ▪ Smoking Cessation ▪ Exercise ▪ Weight control ▪ Mediterranean diet ▪ Angina control ▪ Beta-blockers ▪ Calcium channel blockers ▪ Nitrates ▪ Ranexa ▪ BB / amlodipine combo >> diltiazem / nitrate combo ▪ What about Aspirin?

Stable CAD – What do you do with a negative stress test? ▪ If in doubt, confirm dx of CAD with CT calcium score ▪ Begin cardiac risk factor modification ▪ Lower SBP to < 140 mm Hg ▪ Reduce LDL by 50% ▪ Smoking Cessation ▪ Exercise ▪ Weight control ▪ Mediterranean diet ▪ Angina control ▪ Beta-blockers ▪ Calcium channel blockers ▪ Nitrates ▪ Ranexa ▪ BB / amlodipine combo >> diltiazem / nitrate combo ▪ What about Aspirin? ▪ Only women who are at high risk for MI or CVA should be prescribed ASA ▪ ASA is recommended in men, especially those > 45 years.

New Lipid Guidelines

When to Cath in Stable Angina ▪ Symptoms despite therapy ▪ Abnormal functional test ▪ Unsure diagnosis ▪ High probability / high risk ▪ Hx stents, CABG, etc. ▪ Change in ECG Radial Heart Cath / PCI ▪ Lower risk ▪ More convenient for patients

PCI for Stable Angina Courage Trial ▪ Everyone got a cath first to exclude left main or serious 3 vessel CAD ▪ Large number of medically only treated patients crossed over to PCI due to inadequate angina control ▪ Once serious CAD is excluded in stable angina patients, ▪ PCI does not prevent MI ▪ PCI does not extend life

Unstable CAD ▪ Diagnostic test of choice: ECG ▪ If ECG is negative, check the cardiac troponin level

STEMI ▪ Must check ECG within 10 mins of presentation ▪ Dx: Symptoms + ST elevation ▪ Must get into cath lab within 90 mins or 120 mins if a transfer patient ▪ This includes “Inpatients” ▪ Upfront Meds ▪ ASA 325 mg ▪ Heparin ▪ UFH 4000 units ▪ Lovenox 30 mg IV ▪ ? Thienopyridine ▪ ? 2B/3A inhibitor bolus ▪ No clear benefit of routine upfront beta-blockers and nitrates

Time Is Muscle The Wavefront of Necrosis

Acute MI Stent Therapy

Unstable CAD – Non STEMI Why would NSTEMI be more likely to die? ▪ Treat as aggressive as you do with STEMI!

Unstable CAD

Unstable CAD – What’s next in unstable angina ▪ TIMI – 0 ▪ Evaluate for non-cardiac chest pain ▪ TIMI – 1 or 2 ▪ Consider stress test ▪ Risk factor modification ▪ Medical therapy for CAD ▪ TIMI – 3 or more ▪ Consider cath ▪ Risk factor modification ▪ Medical therapy for CAD

Follow-up Care ▪ Things You Need to Know First ▪ Did the patient have unstable CAD? ▪ Did the patient have a DES? ▪ Is the patient diabetic? ▪ What is the LVEF? ▪ What is the baseline LDL? ▪ Did the patient have unstable CAD – regardless of initial tx? ▪ Needs DAPT for 9 months ▪ Brilinta or Effient preferred over Plavix

Follow-up Care ▪ Things You Need to Know First ▪ Did the patient have unstable CAD? ▪ Did the patient have a DES? ▪ Is the patient diabetic? ▪ What is the LVEF? ▪ What is the baseline LDL? ▪ Did the patient have unstable CAD – regardless of initial tx? ▪ Needs beta-blocker therapy for at least 12 months (preferably 24 months)

Follow-up Care ▪ Things You Need to Know First ▪ Did the patient have unstable CAD? ▪ Did the patient have a DES? ▪ Is the patient diabetic? ▪ What is the LVEF? ▪ What is the baseline LDL? ▪ Did the patient have a drug- eluting stent? ▪ Needs DAPT for 12 months ▪ Brilinta or Effient preferred in unstable CAD presentations ▪ Plavix is OK in stable presentations ▪ What about bare metal stents? ▪ DAPT is needed for 6 – 12 weeks.

Elective Surgery and DAPT after PCI

Follow-up Care ▪ Things You Need to Know First ▪ Did the patient have unstable CAD? ▪ Did the patient have a DES? ▪ Is the patient diabetic? ▪ What is the LVEF? ▪ What is the baseline LDL? ▪ Is the patient diabetic? ▪ If unstable presentation, requires aldactone 12.5 mg – 25 mg daily ▪ Can raise potassium levels and cause sore breasts in men

Follow-up Care ▪ Things You Need to Know First ▪ Did the patient have unstable CAD? ▪ Did the patient have a DES? ▪ Is the patient diabetic? ▪ What is the LVEF? ▪ What is the baseline LDL? ▪ What is the LVEF? ▪ < 35% ▪ CHF approved beta-blocker ▪ Carvedilol ▪ Toprol XL ▪ Bisoprolol ▪ ACE or ARB ▪ Aldactone

Follow-up Care ▪ Things You Need to Know First ▪ Did the patient have unstable CAD? ▪ Did the patient have a DES? ▪ Is the patient diabetic? ▪ What is the LVEF? ▪ What is the baseline LDL? ▪ With CAD, need a > 50% reduction in LDL

PCSK9 -- What is it?

What do PCSK9 inhibitors do…

How do you give it?

Follow-Up Studies ▪ ECG ▪ LBBB ▪ Arrhythmias ▪ BMP within 2-4 weeks of aldactone start ▪ VerifyNow in Plavix users ▪ LDL in 8 weeks to confirm > 50% reduction from baseline; repeat again for med changes ▪ For newly recognized LVEF < 35%, repeat echo in 90 days, and then annually ▪ For LVEF < 35% after 90 days, consider ICD ▪ For “high risk” patients post stent implantation, consider stress test at year one

Follow-Up Studies - Symptoms ▪ ECG ▪ Is there a change? ▪ Echo ▪ Is there a new WMA? ▪ Is there a change in LVEF? ▪ Stress test ▪ Lab ▪ Hemogram ▪ BMP ▪ ? TSH ▪ When to order CTA… ▪ Early symptoms after CABG ▪ Inconclusive stress test ▪ Negative stress test and persistent symptoms ▪ Suspicion for coronary anomaly

Follow-Up Studies - Symptoms ▪ When to order cardiac cath… ▪ Early symptoms after CABG or stent implantation ▪ Abnormal or Inconclusive stress test ▪ Negative stress test and persistent symptoms ▪ Concern for unstable angina

Thanks for listening!